Surgery Partners, Inc. (NASDAQ: SGRY) reported Q1 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $776 million versus the consensus estimate of $778.04 million.

2025 Guidance

Full year 2025 revenue and Adjusted EBITDA guidance reaffirmed to be in the range of $3.30 billion to $3.45 billion and $555 million to $565 million, respectivel

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.